Expression of Fas/CD95 and Bcl-2 by primitive hematopoietic progenitors freshly isolated from human fetal liver

被引:60
作者
Barcena, A [1 ]
Park, SW [1 ]
Banapour, B [1 ]
Muench, MO [1 ]
Mechetner, E [1 ]
机构
[1] INGENEX INC, MENLO PK, CA USA
关键词
D O I
10.1182/blood.V88.6.2013.bloodjournal8862013
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The cell-surface expression and the functional status of the CD95/Fas antigen on primitive hematopoietic progenitors PHPs) freshly isolated from human fetal liver (FL) were studied. PHPs were phenotypically defined as CD34(++)CD38(-/+) cells. The most immature subfractions of PHPs, CD34(++)CD38(-) and CD34(++)CD38(+) FL cells, expressed CD95, whereas the more mature CD34(++)CD38(++) and CD34(+)CD38(++) FL cells displayed low CD95 expression. Combinations of cytokines, such as kit ligand (KL) + interleukin-3 or KL + granulocyte-macrophage colony-stimulating factor (GM-CSF) upregulated the expression of CD95 on PHPs upon in vitro culture. Tumor necrosis factor-alpha (TNF-alpha) and interferon-gamma (IFN-gamma) further increased the CD95 expression induced by KL + GM-CSF. The hematopoietic potential of sorted CD34(++)lineage (lin)(-) CD95(+) versus CD34(++)lin(-)CD95(-) FL cells was compared by colony-forming unit-culture (CFU-C) assays performed in serum-deprived medium. Lin(+) cells were composed of erythrocytes, monocytes, T cells, B cells, and natural killer cells. Our results indicated that both CD95(-) and CD95(+) subsets contained pluripotent progenitors, generating myeloid and erythroid progenitors. The functional status of CD95 and the effects of TNF-alpha and IFN-gamma, cytokines known to induce CD95-mediated apoptosis, were analyzed by incubation of PHPs in the presence of anti-CD95 monoclonal antibodies (MoAbs). The effect of anti-CD95 MoAbs was measured by viable cell counting, flow cytometry, and CFU-C assays. A decrease of CFU-C numbers was observed in the presence of anti-CD95 MoAbs and TNF-alpha and/or IFN-gamma. However, whereas growth factor deprivation induced apoptosis of PHPs, cross-linking of CD95 did not lead to apoptosis of PHPs measured by flow cytometry and viable cell counting. The correlation of increased intracytoplasmic levels of bcl-2 with high levels of cell-surface CD34 and the presence of CD95 on fresh FL cells suggests that bcl-2 may be involved in protecting against CD95-mediated apoptosis of FL PHPs. (C) 1996 by The American Society of Hematology.
引用
收藏
页码:2013 / 2025
页数:13
相关论文
共 61 条
[51]   TRANSGENIC T-CELL RECEPTOR INTERACTIONS IN THE LYMPHOPROLIFERATIVE AND AUTOIMMUNE SYNDROMES OF LPR AND GLD MUTANT MICE [J].
SIDMAN, CL ;
MARSHALL, JD ;
VONBOEHMER, H .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1992, 22 (02) :499-504
[52]   MOLECULAR-CLONING AND EXPRESSION OF THE FAS LIGAND, A NOVEL MEMBER OF THE TUMOR-NECROSIS-FACTOR FAMILY [J].
SUDA, T ;
TAKAHASHI, T ;
GOLSTEIN, P ;
NAGATA, S .
CELL, 1993, 75 (06) :1169-1178
[53]   T-CELL APOPTOSIS DETECTED IN-SITU DURING POSITIVE AND NEGATIVE SELECTION IN THE THYMUS [J].
SURH, CD ;
SPRENT, J .
NATURE, 1994, 372 (6501) :100-103
[54]  
TERSTAPPEN LWMM, 1991, BLOOD, V77, P1218
[55]   CLONING OF THE CHROMOSOME BREAKPOINT OF NEOPLASTIC B-CELLS WITH THE T(14-18) CHROMOSOME-TRANSLOCATION [J].
TSUJIMOTO, Y ;
FINGER, LR ;
YUNIS, J ;
NOWELL, PC ;
CROCE, CM .
SCIENCE, 1984, 226 (4678) :1097-1099
[56]  
WATANABEFUKUNAGA R, 1992, J IMMUNOL, V148, P1274
[57]   LYMPHOPROLIFERATION DISORDER IN MICE EXPLAINED BY DEFECTS IN FAS ANTIGEN THAT MEDIATES APOPTOSIS [J].
WATANABEFUKUNAGA, R ;
BRANNAN, CI ;
COPELAND, NG ;
JENKINS, NA ;
NAGATA, S .
NATURE, 1992, 356 (6367) :314-317
[58]   ANTI-FAS APO-1 ANTIBODY-MEDIATED APOPTOSIS OF CULTURED HUMAN GLIOMA-CELLS - INDUCTION AND MODULATION OF SENSITIVITY BY CYTOKINES [J].
WELLER, M ;
FREI, K ;
GROSCURTH, P ;
KRAMMER, PH ;
YONEKAWA, Y ;
FONTANA, A .
JOURNAL OF CLINICAL INVESTIGATION, 1994, 94 (03) :954-964
[59]  
WONG GHW, 1994, J IMMUNOL, V152, P1751
[60]   A CELL-KILLING MONOCLONAL-ANTIBODY (ANTI-FAS) TO A CELL-SURFACE ANTIGEN CO-DOWNREGULATED WITH THE RECEPTOR OF TUMOR NECROSIS FACTOR [J].
YONEHARA, S ;
ISHII, A ;
YONEHARA, M .
JOURNAL OF EXPERIMENTAL MEDICINE, 1989, 169 (05) :1747-1756